Americans paid more visits to alternative therapy practitioners than they did to primary care physicians in 1997.
Americans paid more visits to alternative therapy practitioners than they did to primary care physicians in 1997, according to a new study published in the Journal of the American Medical Association.
The study, which appeared in the Nov. 11, 1998 issue, was a follow-up to a similar survey conducted in 1991. Researchers asked 2,055 adults via telephone whether they had used an alternative medicine or therapy within the last year.
According to participants' responses, researchers concluded that Americans paid approximately 628.8 million visits to alternative therapy practitioners in 1997. That's roughly 243 million more visits than were paid to primary care physicians, and approximately 47% more visits than were reported in 1990.
Researchers found that "use of at least one of 16 alternative therapies during the previous year increased from 33.8% to 42.1% in 1997." The 16 therapies included in the survey were herbal medicine, massage, chiropractic, relaxation techniques, megavitamin use, self-help groups, "lifestyle diet" use, energy healing, homeopathy, hypnosis, biofeedback, imagery, spiritual healing, acupuncture, commercial diet use and folk remedies.
Of these, the most commonly used therapies included herbal medicine, massage, megavitamins, self-help groups, folk remedies, energy healing and homeopathy. Therapies were used most often for chronic conditions such as back problems, anxiety, depression and headache.
Researchers also found that an estimated 15 million adults in 1997 took prescription medications concurrently with herbal remedies and high-dose vitamins. "Among the 44% of adults who said they regularly take prescription medicines, nearly one in five reported the concurrent use of at least one herbal product, a high-dose vitamin or both," according to the study.
Disturbingly, however, there was no significant increase in the rate of disclosure about alternative therapy use to physicians.
Patients who visited alternative therapy practitioners saw physicians, but did not share information about their alternative therapy with their doctors. The researchers noted: "As in 1990, 96% of 1997 respondents who saw a practitioner of alternative therapy for a principal condition also saw a medical doctor during the prior 12 months, and only a minority of alternative therapies used were discussed with a medical doctor." In comparison, 39.8% of patients told their physicians they were using alternative therapies in 1990. That disclosure rate fell to 38.5% in 1997. PR
Sanofi Bolsters Immunology Pipeline with Acquisition of Dren Bio’s DR-0201 for Up to $1.9 Billion
March 20th 2025DR-0201, a CD20-directed bispecific antibody, has demonstrated robust B-cell depletion in early clinical studies, showing promise in treating refractory B-cell-mediated autoimmune diseases.
The Misinformation Maze: Navigating Public Health in the Digital Age
March 11th 2025Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
Phase III Trials Show Povorcitinib Significantly Improves Hidradenitis Suppurativa Outcomes
March 19th 2025In the Phase III STOP-HS1 and STOP-HS2 trials, results show that patients treated with povorcitinib for hidradenitis suppurativa experienced a ≥50% reduction in the total abscess and inflammatory nodule count.